StageZero Life Sciences Offers BORDERPASS(TM) COVID-19 PCR Test Kits for Travelers

Rhea-AI Summary

StageZero Life Sciences has launched its BORDERPASS™ COVID-19 RT-PCR saliva test kits available in over 400 Sobeys Inc. pharmacies across Canada. This innovative testing solution enables travelers to collect samples conveniently at home or hotels under video supervision. Results are provided within 24 hours of sample arrival. The BORDERPASS™ test is accepted at borders in Canada, the U.S., and internationally. This offering aligns with StageZero's Global Growth Strategy and is set to meet increasing travel demands during the holiday season.

Positive

• Launch of BORDERPASS™ COVID-19 test kits in over 400 Sobeys pharmacies enhances accessibility for travelers.
• Results delivered within 24 hours provide convenience and peace of mind for users.
• Strategic partnerships with Sobeys Inc. support the company's Global Growth Strategy.

Negative

• None.

Convenient, reliable COVID-19 PCR saliva test kits available at Sobeys Inc. pharmacies across Canada

TORONTO, ON and RICHMOND, VA / ACCESSWIRE / December 6, 2021 / StageZero Life Sciences, Ltd. (TSX:SZLS) ("StageZero" or the "Company"), a vertically integrated healthcare company devoted to improving the early detection and management of cancer and other chronic diseases through leading-edge molecular diagnostics and clinical interventions, today announced its BORDERPASS™ COVID-19 RT-PCR saliva test kits are available for purchase at more than 400 Sobeys Inc. pharmacy banners across Canada, including Lawtons, Safeway and Sobeys.

StageZero has been a leader in COVID-19 diagnostics since the early days of the pandemic, offering COVID-19 tests since April 2020. Announced in November 2021, BORDERPASS™ is the company's latest innovation in testing. The BORDERPASS™ RT-PCR saliva test kit makes it easy and convenient for travelers to take their COVID PCR test without scrambling to find a PCR clinic when they are on the road. The easy-to-use test kit allows travelers to self-collect their COVID PCR saliva sample from the comfort of their home, office, or hotel room under video supervision of a healthcare professional using Ichor Blood Services' video conferencing capabilities. Travelers simply ship their sample to the StageZero laboratory via provided FedEx packaging and they receive test results via email within 24 hours of their sample arriving at the lab. BORDERPASS™ PCR test results are accepted at Canadian, U.S., and most international borders.

As part of the Company's broader Global Growth Strategy, StageZero continues to grow its strategic corporate relationships through specialized partnerships and its BORDERPASS™ offering.

"With the holidays upon us, many people are planning trips to see family and enjoy time off in international destinations," said James Howard-Tripp, Chairman and CEO of StageZero Life Sciences. "We are very pleased to have BORDERPASS™ test kits conveniently available in Lawtons, Safeway and Sobeys pharmacies across Canada. With BORDERPASS™, we are providing travelers with the convenience of not having to search for a clinic and the peace of mind knowing that their PCR test results will be accepted at the border."

"We think of Sobeys as a family nurturing families. That purpose has become more important than ever during the pandemic, and underlies our efforts around COVID-19 safety and wellbeing," said Marie-Claude Vézina, VP and General Manager Pharmacy, at Sobeys Inc. "Over the past year we've played a leading role in delivering COVID-19 vaccines in our national pharmacy network in Canada. Today, we're pleased to collaborate with StageZero Life Sciences to make BORDERPASS™ COVID-19 PCR test kits available to help keep customers safe while traveling."

BORDERPASS™ test kits for individuals are available for purchase at Sobeys Inc. pharmacy banners including Lawtons, Safeway and Sobeys across Canada and online. For more information, please visit www.stagezeroborderpass.com.

# # #

About StageZero Life Sciences, Ltd.

StageZero Life Sciences, Ltd. is a vertically integrated healthcare company dedicated to improving the early detection and management of cancer and other chronic diseases through next-generation diagnostics and a unique telehealth program that provides clinical interventions to help patients reduce the risk of developing late-stage disease (AVRT™).

The Company's next generation test, Aristotle®, is the first ever multi-cancer panel for simultaneously screening for multiple cancers from a single sample of blood with high sensitivity and specificity for each cancer. Aristotle® uses mRNA technology to identify the molecular signatures of multiple cancer types and is built on the Company's patented technology platform, the Sentinel Principle. This underlying technology has been validated in more than 9,000 patients and used by more than 100,000 patients in North America.

Aristotle®, as well as additional cancer diagnostics (ColonSentry®, BreastSentry™, and the Prostate Health Index) are processed at the Company's clinical laboratory, StageZero Life Sciences, Inc., a CAP accredited and CLIA certified high-complexity reference laboratory in Richmond, Virginia. In addition, the Company is also leveraging its specialty in polymerase chain reaction (PCR) testing to provide COVID-19 PCR testing (swab and saliva) and Antibody Testing (blood analysis).

StageZero Life Sciences trades on the Toronto Stock exchange under the symbol SZLS and on the OTCQB under the symbol SZLSF.

Forward-Looking Statements

This press release contains forward-looking statements identified by words such as "expects", "will" and similar expressions, which reflect the Company's current expectations regarding future events. The forward-looking statements involve risks and uncertainties that could cause the Company's actual events to differ materially from those projected herein. Investors should consult the Company's ongoing quarterly filings and annual reports for additional information on risks and uncertainties relating to these forward-looking statements. The reader is cautioned not to rely on these forward-looking statements. The Company disclaims any obligation to update these forward-looking statements, except as required by law.

For further information please contact:

Investor Relations
Rebecca Greco
1-855-420-7140 ext. 1838
rgreco@stagezerols.com

Media Contact
Kristin Villiotte
SHIFT Communications
kvilliotte@shiftcomm.com

SOURCE: StageZero Life Sciences Ltd

View source version on accesswire.com:
https://www.accesswire.com/676138/StageZero-Life-Sciences-Offers-BORDERPASSTM-COVID-19-PCR-Test-Kits-for-Travelers

FAQ

What are the features of the BORDERPASS™ COVID-19 test kits offered by SZLSF?

The BORDERPASS™ COVID-19 RT-PCR saliva test kits allow travelers to self-collect samples at home or hotels, with video supervision from a healthcare professional. Results are emailed within 24 hours of sample receipt.

Where can I purchase BORDERPASS™ COVID-19 test kits from SZLSF?

BORDERPASS™ test kits are available for purchase at Sobeys Inc. pharmacy banners including Lawtons, Safeway, and Sobeys across Canada, as well as online.

What is the significance of the partnership between SZLSF and Sobeys Inc.?

The partnership allows StageZero Life Sciences to expand the accessibility of its PCR test kits to a broader audience, aligning with its Global Growth Strategy.

How quickly can I expect results from the BORDERPASS™ test?

Test results from the BORDERPASS™ PCR test are provided within 24 hours of the sample arriving at the StageZero laboratory.

Is the BORDERPASS™ test accepted internationally?

Yes, BORDERPASS™ PCR test results are accepted at the borders in Canada, the U.S., and most international destinations.